Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bide Pharmatech Co's share price for the quarter that ended in Mar. 2026 was ¥55.4. Bide Pharmatech Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 91 Mil. Therefore, Bide Pharmatech Co's market cap for the quarter that ended in Mar. 2026 was ¥5,035 Mil.
Bide Pharmatech Co's quarterly market cap
declined
from Sep. 2025 (¥6,990 Mil) to Dec. 2025 (¥5,548 Mil) and
declined
from Dec. 2025 (¥5,548 Mil) to Mar. 2026 (¥5,035 Mil).
Bide Pharmatech Co's annual market cap
declined
from Dec. 2023 (¥5,044 Mil) to Dec. 2024 (¥4,468 Mil) but then
increased
from Dec. 2024 (¥4,468 Mil) to Dec. 2025 (¥5,548 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bide Pharmatech Co's Enterprise Value for Today is ¥3,269 Mil.
Bide Pharmatech Co (SHSE:688073) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bide Pharmatech Co Market Cap Related Terms
Bide Pharmatech Co Market Cap Historical Data
* Premium members only.
The historical data trend for Bide Pharmatech Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bide Pharmatech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bide Pharmatech Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bide Pharmatech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Bide Pharmatech Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bide Pharmatech Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bide Pharmatech Co (SHSE:688073) has a Market Cap of ¥4,603 Mil as of Aug. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bide Pharmatech Co and its competitors. According to the industry distribution chart, Bide Pharmatech Co ranks #330 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 32.2%.
Is Bide Pharmatech Co's Market Cap too high?
Bide Pharmatech Co's current Market Cap is ¥4,603 Mil. Based on the distribution chart, Bide Pharmatech Co ranks #330 out of 1024 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bide Pharmatech Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bide Pharmatech Co's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bide Pharmatech Co ranks #330 out of 1024 companies for Market Cap. This puts Bide Pharmatech Co in the upper half of its industry. The industry median Market Cap is 214.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.68, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bide Pharmatech Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bide Pharmatech Co's current Market Cap is ¥4,603 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bide Pharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, Bide Pharmatech Co (SHSE:688073) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥67.40, compared to a current price of ¥50.65 — trading 24.9% below its estimated fair value. The current Market Cap is ¥4,603 Mil. Bide Pharmatech Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bide Pharmatech Co (SHSE:688073), the current Market Cap is ¥4,603 Mil as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bide Pharmatech Co (SHSE:688073) Overvalued in 2026?
Based on GuruFocus' analysis, Bide Pharmatech Co stock appears to be undervalued.
The current stock price of ¥50.65 is trading 24.9% below its estimated GF Value™ of ¥67.40.
GuruFocus considers Bide Pharmatech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688073:
Market Cap: ¥4,603 Mil
GF Value™: ¥67.40 vs. price of ¥50.65 (24.9% below fair value)
No single metric tells the full story. See the SHSE:688073 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688073 has been successfully added to your 
